Treponema pallidum particle agglutination assay

TPHA test on microplate wells

Treponema pallidum particle agglutination assay (TPPA) is a laboratory test used for the serological detection of antibodies against Treponema pallidum, the bacterium that causes syphilis. This test is highly specific and is commonly used in the diagnosis and confirmation of syphilis, particularly in cases where other tests may give ambiguous results. The TPPA test is considered one of the most reliable methods for serological diagnosis of syphilis, complementing other non-treponemal tests such as the Rapid Plasma Reagin (RPR) test or the Venereal Disease Research Laboratory (VDRL) test.

Overview

The TPPA test operates on the principle of agglutination, where gelatin particles coated with T. pallidum antigens are mixed with the patient's serum. If antibodies against T. pallidum are present in the serum, they will bind to the antigens on the particles, causing them to clump together, or agglutinate. This agglutination is visible to the naked eye and indicates a positive result. The absence of agglutination suggests that the patient does not have antibodies against T. pallidum, indicating a negative result.

Procedure

The procedure for the TPPA test involves several steps:

1. Serum is extracted from a blood sample taken from the patient.
2. The serum is then diluted and added to a test plate or tube containing the antigen-coated particles.
3. The mixture is incubated at a specific temperature for a predetermined period.
4. After incubation, the test is examined for the presence or absence of agglutination.

Interpretation of Results

A positive TPPA test indicates that the patient has antibodies against T. pallidum, suggesting a current or past infection with syphilis. However, a positive result should be interpreted in the context of clinical findings and other laboratory tests. A negative TPPA test suggests the absence of syphilis infection, but in early stages of the disease, the body may not have produced enough antibodies to be detected, leading to a false-negative result. Therefore, in cases of suspected early syphilis, the test may need to be repeated after some time.

Advantages and Limitations

The TPPA test is highly specific for T. pallidum antibodies, making it a valuable tool for confirming syphilis diagnosis. However, like all diagnostic tests, it has its limitations. The test does not distinguish between past and current infections, and a positive result may persist even after successful treatment of syphilis. Additionally, the test requires specialized laboratory equipment and trained personnel to perform and interpret the results.

Clinical Significance

The TPPA test plays a crucial role in the diagnosis and management of syphilis. It is often used in conjunction with non-treponemal tests to confirm a diagnosis, especially in cases where the initial screening results are equivocal. Early detection and treatment of syphilis are essential to prevent the progression of the disease and reduce the risk of transmission.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian